Mesonephric duct development

pathway activity — cross-omics
GO:0072177Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Mesonephric duct development pathway is significantly associated with the RNA expression of multiple genes, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are NCF2, SMIM6, and TRMT2B-AS1, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Mesonephric duct development activity versus NCF2 in LUAD (Pearson r = -0.20).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADNCF2 →-0.461-0.290.004.00834
LUADSMIM6 →+0.509+0.311<.001<.00134
LSCCTRMT2B-AS1 →+0.694+0.353<.001<.00133
BRCADLX4 →+0.830+0.381<.001.00133
CCRCCTSFM →+0.254+0.477.005.00533
LSCCSLC16A3 →-0.410-0.214.001.00433
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0072177 vs NCF2 — LUAD

Per-sample scatter of Mesonephric duct development activity vs NCF2 in LUAD.

Explore this scatter interactively →

Exploration